Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsAltering the tropism of lentiviral vectors through pseudotyping.Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidolInfectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexesCorrection of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapySelection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA libraryProgresses towards safe and efficient gene therapy vectorsIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinHuman serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesRole of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus EntryThe association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entryPrimate TRIM5 proteins form hexagonal nets on HIV-1 capsids.Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza.Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.Protein transduction from retroviral Gag precursorsA concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly.Gammaretroviral vectors: biology, technology and applicationCharacterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.Library screening and receptor-directed targeting of gammaretroviral vectors.Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alphaInduction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza virusesStem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virusAntiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsEbola virus glycoproteins: guidance devices for targeting gene therapy vectors.Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice.Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Retroviral env glycoprotein trafficking and incorporation into virions.Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
P2860
Q21089621-61038FFF-BC5D-41FC-B415-89E30AC79FE3Q24538987-2535DCEA-CDAB-4EC3-B225-257F5EA6AC26Q24653452-4C1B0EC5-048D-429D-B307-80A8A6254F17Q24673768-54EB6960-C5B5-4FF0-9D53-EB3A0C7D9971Q24685725-AD98431C-4DF7-444D-9F01-38FE36A4C56BQ24804591-3F0389CE-F6EA-4427-B457-3E1E8A9980C1Q26781432-BED78609-D8DC-477A-968E-FFADF117B244Q27333881-5AC59581-3D87-42DD-BED3-CC5D22C75BF7Q27469507-E641D48D-49DE-4849-8B54-1ADCB0AD6375Q27469837-E90E8F29-244B-46E5-A818-E75BAA7B1B5CQ27469844-AA74CB16-2B70-4AE0-9307-6C3FE45A2697Q27485588-A66390E5-18DC-48AE-A316-5F89465B8DB3Q27488727-9B130E07-59C3-4C96-B560-8749320C7DCEQ30276687-F3C1EE57-A406-4A20-B9B4-B8205C5C73C4Q30375938-3E81AA91-C0FC-4E09-97F4-F8140714F984Q30447936-C1590B8E-D292-424E-A8FD-13F02903CC62Q30479723-C360CB37-2E99-4B3D-A8A4-4DD2973E658EQ30495724-1701E118-3B33-40EF-8FF0-1AC6AFF1F61EQ33822226-A5382603-4C2A-4DB8-9F4C-E56A4AA3F0AFQ33842785-9E0CB4FD-49C6-491F-823C-ECFC033FDD77Q33981285-D9F6618D-E4B3-4493-AC0D-975AB2BF6E63Q34223822-39B44167-6091-4863-8B10-8911907C4B9AQ34393161-2572D477-34BB-49A3-ACCB-35404938C562Q34439347-A1D137BB-7561-4D01-A899-74D46B79DD34Q34517833-BAAA7CD3-37E7-4AEB-AA6E-4506FF1DC4EFQ34976813-4AC871A6-FB22-4060-84BB-1070058DB98AQ35038863-8ACDFCDB-4729-44CA-B23A-18B13E72B160Q35086128-CB45AA77-ADD7-4B7D-8F68-E9106EBB8EA6Q35543014-D5E3D429-3D03-4601-BC03-FEAFA9059932Q35543170-59BED1D5-7C22-4E00-A97A-50B0AEC7D209Q35605579-A1957956-6055-456D-B1D6-10BC48F279C1Q35666025-73A24D98-A2C4-4935-A3B6-03B406BDC2E8Q35684857-1ADAA13C-0710-4021-86D3-93DAE899B83EQ35776114-81510C82-04F2-4C55-8870-47E76AFB1C71Q35847830-99CEC5B6-D7C2-44C2-8A05-D4F2448B4753Q35914270-EE85B457-699E-40A6-A85A-313F31503467Q36086635-98EC08E6-3B6F-4365-A0BF-519798239E2DQ36090433-DBD5656A-9832-4519-B54D-F687B5448D8FQ36114246-CDFCD326-C7DE-4F90-B4C4-BC93B142D8FDQ36186475-CC33FD9F-E5A2-4421-8534-0480ACC16D95
P2860
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Lentiviral vectors pseudotyped ...... m human and nonhuman primates.
@en
type
label
Lentiviral vectors pseudotyped ...... m human and nonhuman primates.
@en
prefLabel
Lentiviral vectors pseudotyped ...... m human and nonhuman primates.
@en
P2093
P50
P1433
P1476
Lentiviral vectors pseudotyped ...... om human and nonhuman primates
@en
P2093
Didier Trono
Roger Le Grand
Virginie Sandrin
Wilfried Gay
P304
P356
10.1182/BLOOD-2001-11-0042
P407
P577
2002-08-01T00:00:00Z